Glenmede Trust’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Glenmede Trust’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-300	Closed	-$29K	–	2528
2020 Q3	$29K	Hold	300	–	–	﹤0.01%	1476
2020 Q2	$36K	Hold	300	–	–	﹤0.01%	1401
2020 Q1	$31K	Hold	300	–	–	﹤0.01%	1888
2019 Q4	$31K	Hold	300	–	–	﹤0.01%	1888
2019 Q3	$34	Hold	300	–	–	﹤0.01%	1834
2019 Q2	$51	Sell	300 -15	-5%	-$2.59K	﹤0.01%	1670
2019 Q1	$53	Hold	315	–	–	﹤0.01%	1659
2018 Q4	$30	Buy	+315	New	+$41.3K	﹤0.01%	1814
2018 Q3	–	Sell	-315	Closed	-$44K	–	1926
2018 Q2	$44K	Buy	315 +100	+47%	+$14.2K	﹤0.01%	1484
2018 Q1	$28K	Hold	215	–	–	﹤0.01%	1838
2017 Q4	$28K	Hold	215	–	–	﹤0.01%	1838
2017 Q3	$21K	Buy	215 +200	+1,333%	+$21.4K	﹤0.01%	1956
2017 Q2	$1K	Hold	15	–	–	﹤0.01%	2621
2017 Q1	$1K	Hold	15	–	–	﹤0.01%	2621
2016 Q4	$1K	Buy	+15	New	+$1.8K	﹤0.01%	2432

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Glenmede Trust's GWPH Position: Q4 2020 in Review

Glenmede Trust sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 300 shares — an estimated $29K sold.

Glenmede Trust first reported a position in GWPH in Q4 2016 and held it in 15 quarters. The position peaked at $44K in Q2 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Glenmede Trust reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 300 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $29K.
Glenmede Trust first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 15 quarters.
Glenmede Trust's GW Pharmaceuticals Plc American Depositary Shares position peaked at $44K in Q2 2018.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.